NPY, neuropeptide Y, 4852

N. diseases: 381; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE In this study, we investigated whether NPY has a protective role in ER stress-induced neuronal cell death in SK-N-SH human neuroblastoma cells. 29650257 2018
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE A human neuroblastoma cell line (SH-SY5Y) was used to assess in vitro whether an AAV vector manufactured to clinical-grade protocols would be effective at transducing these cells to express NPY. 29367144 2018
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE Our findings validate NPY as a therapeutic target for advanced NB and implicate the NPY/Y5R axis in disease dissemination. 27743558 2016
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE Additionally, NPY and Y5R were upregulated in a BDNF-independent manner in NB cells under pro-apoptotic conditions, such as serum deprivation and chemotherapy, as well as in cell lines and tissues derived from posttreatment NB tumors. 25132261 2015
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE Finally, we recapitulate our recent in-vitro evidence for the involvement of neurotrophin nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in the neuroprotective effect elicited by NPY in AD neuron-like models (neuroblastoma cells or primary cultures exposed to toxic concentrations of Aβ's pathogenic fragment 25-35), and propose a putative mechanism based on NPY-induced inhibition of voltage-dependent Ca(2+) influx in pre- and post-synaptic neurons. 25026432 2014
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE We have used human neuroblastoma SH-SY5Y cells to investigate the effect of valproate (VPA) and amitriptyline (AMI) on NPY expression at therapeutic plasma concentrations of 0.6mM and 630nM, respectively. 23994577 2013
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE NPY protected human SH-SY5Y dopaminergic neuroblastoma cells from 6-hydroxydopamine-induced toxicity. 21816512 2012
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE Both NPY and Y2Rs are commonly expressed in neuroblastoma cell lines and tissues. 20676138 2010
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE These observations suggest that the expression of NPY in SH-SY5Y human neuroblastoma cells is negatively regulated by RA at the level of gene expression, probably by mechanisms involving the interaction of activated RARs with transcription factors (such as AP-1). 10854907 2000
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE This occurred concomitant with induction of neurite outgrowth and expression of the neuronal marker genes GAP-43 and neuropeptide Y. Constitutive expression of exogenous HASH-1 did not alter the capacity of the neuroblastoma cells to differentiate in response to differentiation-inducing agents. 10080936 1999
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE In the present study, we have investigated whether these changes in CRE binding transcriptional factors activated by NPY results in gene regulation using a human neuroblastoma cell line (SK-N-BE2). 9802424 1998
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE In conclusion, the present study shows that the activation of PKC-coupled muscarinic receptors as the M3 subtype positively modulates the expression of the human NPY gene in SH-SY5Y neuroblastoma cells, via PKC-related mechanisms. 9666082 1998
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE NPY mRNA expression in neuroblastoma tissue was assessed by Northern blot analysis. 9802408 1998
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE The suppression of neuropeptide Y Y1 receptor gene expression by antisense oligonucleotides targeted to different gene regions was monitored on mRNA and protein level in the human neuroblastoma SK-N-MC cell line. 9228417 1997
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE Potassium currents were evoked by neuropeptide Y in oocytes injected with polyadenylated RNA or with cRNA from pools of a neuroblastoma (KAN-TS) cDNA library, and progressive subdivision of responding pools yielded a single cDNA. 8643076 1996
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE Transfection of dividing neuroblastoma CHP126 cells with pJDT95npy resulted in the differential expression of chimeric NPY mRNAs derived from each promoter. 7968366 1994
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE These protein complexes appear to contribute to the cell specific expression of the NPY gene and seem to be required during differentiation of SH-SY5Y human neuroblastoma cells further along the sympathetic neuronal lineage induced by either TPA or staurosporine. 8036020 1994
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 Biomarker disease BEFREE Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2. 8123590 1994
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE Thirty-eight neuroblastoma tumors were analyzed for NPY mRNA expression using in situ hybridization. 2393870 1990